HR. 1476In Committee
PLASMA Act
Phases in Medicare Part D manufacturer discount requirements for plasma-derived products over several years instead of applying the full discounts immediately
Plain-English overview
What this bill does
Phases in Medicare Part D manufacturer discount requirements for plasma-derived products over several years instead of applying the full discounts immediately
Key points
- Modify plasma product discounts
- Extend discount phase in schedule
Current status
Where it stands
Status
In Committee
Latest action
2025-02-21 — Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Related context
Topics and policy areas
undefinedBlood and blood diseasesDrug therapyHealthHealth care costs and insuranceManufacturingMedicarePrescription drugs